BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 35887229)

  • 1. The RNA-Binding Protein ELAVL1 Regulates Hepatitis B Virus Replication and Growth of Hepatocellular Carcinoma Cells.
    Kanzaki H; Chiba T; Kaneko T; Ao J; Kan M; Muroyama R; Nakamoto S; Kanda T; Maruyama H; Kato J; Zen Y; Kotani A; Sekiba K; Otsuka M; Ohtsuka M; Kato N
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Insights into the Interaction between the C-Terminal-Deleted BH3-like Motif Peptide of Hepatitis B Virus X Protein and Bcl-x
    Kusunoki H; Sakamoto T; Kobayashi N; Kohno T; Wakamatsu K; Nagata T
    Biochemistry; 2024 Mar; 63(5):632-643. PubMed ID: 38377677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circular RNA cFAM210A, degradable by HBx, inhibits HCC tumorigenesis by suppressing YBX1 transactivation.
    Yu J; Li W; Hou GJ; Sun DP; Yang Y; Yuan SX; Dai ZH; Yin HZ; Sun SH; Huang G; Zhou WP; Yang F
    Exp Mol Med; 2023 Nov; 55(11):2390-2401. PubMed ID: 37907737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LncRNA NKILA inhibits HBV replication by repressing NF-κB signalling activation.
    Zhang X; Li Y; Huan C; Hou Y; Liu R; Shi H; Zhang P; Zheng B; Wang Y; Wang H; Zhang W
    Virol Sin; 2024 Feb; 39(1):44-55. PubMed ID: 37832719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hydrogen Peroxide Inhibits Hepatitis B Virus Replication by Downregulating HBx Levels via Siah-1-Mediated Proteasomal Degradation in Human Hepatoma Cells.
    Yoon H; Lee HK; Jang KL
    Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HBV promotes its replication by up-regulating RAD51C gene expression.
    Peng TW; Ma QF; Li J; Wang X; Zhang CH; Ma J; Li JY; Wang W; Zhu CL; Liu XH
    Sci Rep; 2024 Jan; 14(1):2607. PubMed ID: 38297111
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoxia-inducible factor affects hepatitis B virus transcripts and genome levels as well as the expression and subcellular location of the hepatitis B virus core protein.
    Duchemin NJ; Loonawat R; Yeakle K; Rosenkranz A; Bouchard MJ
    Virology; 2023 Sep; 586():76-90. PubMed ID: 37490813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of p90 Ribosomal S6 Kinase 2 as a Novel Host Protein in HBx Augmenting HBV Replication by iTRAQ-Based Quantitative Comparative Proteomics.
    Yan LB; Yu YJ; Zhang QB; Tang XQ; Bai L; Huang F; Tang H
    Proteomics Clin Appl; 2018 May; 12(3):e1700090. PubMed ID: 29350888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mitochondrial Glycerol-3-Phosphate Dehydrogenase Restricts HBV Replication via the TRIM28-Mediated Degradation of HBx.
    Liu C; Zhao K; Chen Y; Yao Y; Tang J; Wang J; Xu C; Yang Q; Zheng Y; Yuan Y; Sun H; Zhang Y; Zhou Y; Chen J; Wang Y; Wu C; Pei R; Chen X
    J Virol; 2023 May; 97(5):e0058023. PubMed ID: 37166302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-17 promotes melanoma through TRAF2 as a scaffold protein recruiting PIAS2 and ELAVL1 to induce EPHA5.
    Du J; Du Y; Chen L; Liu H
    Biochim Biophys Acta Mol Cell Res; 2023 Oct; 1870(7):119547. PubMed ID: 37481078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic Analyses Identify Therapeutic Targets in Hepatocellular Carcinoma.
    Elmas A; Lujambio A; Huang KL
    Front Oncol; 2022; 12():814120. PubMed ID: 35433463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dynamic proximity interaction profiling suggests that YPEL2 is involved in cellular stress surveillance.
    Turan G; Olgun ÇE; Ayten H; Toker P; Ashyralyyev A; Savaş B; Karaca E; Muyan M
    Protein Sci; 2024 Feb; 33(2):e4859. PubMed ID: 38145972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PLK1-ELAVL1/HuR-miR-122 signaling facilitates hepatitis C virus proliferation.
    Seo Y; Kang Y; Ham Y; Kim MH; Kim SJ; Yoon SK; Jang SK; Park JB; Cho S; Kim JH
    Proc Natl Acad Sci U S A; 2022 Dec; 119(51):e2214911119. PubMed ID: 36512502
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between HuR and tumor drug resistance.
    Ma Q; Lu Q; Lei X; Zhao J; Sun W; Huang D; Zhu Q; Xu Q
    Clin Transl Oncol; 2023 Jul; 25(7):1999-2014. PubMed ID: 36947360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between the ELAVL1 gene single nucleotide polymorphisms and the Genetic Susceptibility to cervical cancer by high resolution melting in a Tunisian population.
    Boudhiba N; Sfar S; Helaoui A; Bouanene I; Hołysz M; Skalska E; Bouchahda H; Jagodziński PP; Kenani A
    Mol Biol Rep; 2023 Mar; 50(3):2559-2567. PubMed ID: 36626067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of hsa_circ_0000280 in regulating vascular smooth muscle cell function and attenuating neointimal hyperplasia via ELAVL1.
    Wang Z; Wang H; Guo C; Yu F; Zhang Y; Qiao L; Zhang H; Zhang C
    Cell Mol Life Sci; 2022 Dec; 80(1):3. PubMed ID: 36477660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role and mechanism of COL3A1 in regulating the growth, metastasis, and drug sensitivity in cisplatin-resistant non-small cell lung cancer cells.
    Ren J; Zhao S; Lai J
    Cancer Biol Ther; 2024 Dec; 25(1):2328382. PubMed ID: 38530094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR/Cas9-Mediated Knockout of the
    Luo SQ; Cao SJ; Zhao Q
    Microorganisms; 2024 Feb; 12(2):. PubMed ID: 38399718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis B virus RNAs co-opt ELAVL1 for stabilization and CRM1-dependent nuclear export.
    Zheng Y; Wang M; Yin J; Duan Y; Wu C; Xu Z; Bu Y; Wang J; Chen Q; Zhu G; Zhao K; Zhang L; Hua R; Xu Y; Hu X; Cheng X; Xia Y
    PLoS Pathog; 2024 Feb; 20(2):e1011999. PubMed ID: 38306394
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.